Boston Scientific
- Mapping and Ablation
- Venous Therapies
- Cardiac Rhythm Management
- Structural Heart
- Interventional Oncology
- Drug-Eluting Technologies
- Coronary
Playback speed
10 seconds
Evolution of the HCC Treatment: Clinical and Dosimetric Recommendations for Y-90
431 views
September 2, 2020
Watch to hear Dr. Riad Salem talk about the role of Y-90, the application, and ...
read more ↘ patient-specific dosimetric aspects that allow you to optimize outcomes.
↖ read less
read more ↘ patient-specific dosimetric aspects that allow you to optimize outcomes.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Interventional Oncology
Wed, Nov 3, 2021
Faculty: Riad Salem , Boston Scientific , Shamar Young , Robert Lewandowski , Juan Gimenez
Faculty: Riad Salem , Boston Scientific , Shamar Young , Robert Lewandowski , Juan Gimenez